Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Wellgistics Health, Inc. - Common Stock (NQ:WGRX)

0.6576 -0.0106 (-1.59%)
Streaming Delayed Price Updated: 10:49 AM EST, Nov 4, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Wellgistics Health, Inc. - Common Stock

Wellgistics Health Enters into LOI to Acquire Kare Rx Hub
KareRx to add plug & play telemedicine pharmacy-support vertical and key manufacturer relationships to Wellgistics' offeringTelemedicine remote dispensing market expected... 
Via Newsfile
Topics Artificial Intelligence Economy Intellectual Property
Web3MediaBreaks – Datavault AI Inc. (NASDAQ: DVLT) Partners with Wellgistics (NASDAQ: WGRX) to Develop Blockchain-Enabled PharmacyChain Smart Contracts
Via Investor Brand Network
Topics Artificial Intelligence
Wellgistics Health Enters into Smart Contract Services Agreement with DataVault AI to Develop Patented PharmacyChain(TM) Manufacturer-to-Patient Blockchain-Enabled Tracking & Dispensing Platform for Prescription Drug Market
Tampa, Florida and Philadelphia, Pennsylvania--(Newsfile Corp. - October 27, 2025) - Wellgistics Health, Inc. (NASDAQ: WGRX) ("Wellgistics"), a leader in next-generation pharmaceutical... 
Via Newsfile
Topics Artificial Intelligence Intellectual Property
Kartoon Studios (NYSE American: TOON) Expands Global Reach as Leading Force in Family Entertainment and Animated Media
Via AB Newswire
Topics Intellectual Property
DefenseNewsBreaks – Datavault AI Inc. (NASDAQ: DVLT) and Wellgistics Health (NASDAQ: WGRX) Partner to Advance Blockchain-Enabled Prescription Drug Tracking
Via Investor Brand Network
Topics Artificial Intelligence
Wellgistics Health Announces Executive Management and Board Changes
Via ACCESS Newswire
Wellgistics Health (NASDAQ:WGRX) and TheracosBio Partner to Expand Nationwide, PBM-Free Access to Brenzavvy(R), an FDA-Approved Diabetes Therapy, Through 6,500+ Pharmacies
Via ACCESS Newswire
DataVault AI and Wellgistics Health Announce Plans for PharmacyChain™ to Implement Manufacturer-to-Patient Blockchain-enabled Smart Contracts for the Prescription Drug Industry to Improve Efficiency and Patient Outcomes
Strategic Alliance Targets Digital Transformation of the $634.32 Billion (1) U.S. Prescription Drug Market Through Blockchain-Enabled Data Monetization and AI-Driven Efficiency Gains 
From Datavault AI Inc.
Via GlobeNewswire
Wellgistics Health Announces Pricing of $5 Million Public Offering
Via ACCESS Newswire
Wellgistics Health Launches Capital Access Program for 6,500+ Pharmacies and Supply Chain Partners, Unlocking up to $1M in Working Capital
Via ACCESS Newswire
Wellgistics Health, Inc. to Present at September Investor Conferences
Via ACCESS Newswire
Wellgistics Health Introduces HubRx AI: Advancing the AI-Powered Prescription Ecosystem
Via ACCESS Newswire
Wellgistics Health Achieves Stability in First-Half 2025 and Executes Growth Initiatives
Via ACCESS Newswire
Wellgistics Health Terminates Equity Line of Credit to Further Support Growth Strategy
Via ACCESS Newswire
Wellgistics Health (NASDAQ: WGRX) Launches XRP Payment Program for Independent Pharmacies
Via ACCESS Newswire
Wellgistics Health Converts $8.1M Debt to Equity
Via ACCESS Newswire
WGRX CEO Brian Norton to Go Live on Floorstocks YouTube — Unfiltered Market Talk at 1 PM EST
From Floorstocks
Via GlobeNewswire
Floorstocks Releases Exclusive Nasdaq MarketSite Interview with Wellgistics Health Inc. (NASDAQ: WGRX)
From Floorstocks
Via GlobeNewswire
Wellgistics Health (NASDAQ:WGRX) Accelerates Platform Growth in Q2 With 116 Manufacturer Partnerships, 12,400+ New Products, and 275+ Pharmacies Added to Its Expanding Tech Based Drug Ecosystem
Via ACCESS Newswire
Wellgistics Health Joins OptiSource to Expand Access and Drive Savings for Independent Pharmacies
Via ACCESS Newswire
Wellgistics Health Announces Preliminary Inclusion in the Russell 2000 and Russell 3000 Indexes
Via ACCESS Newswire
Wellgistics Health Strengthens Executive Team and Board with Strategic Appointments to Accelerate Scale and Drive Shareholder Value
Via ACCESS Newswire
Wellgistics Health Reports 36% Revenue Growth in Q1 2025 as Manufacturer Access and Pharmacy Onboarding Accelerate
Via ACCESS Newswire
CORRECTION FROM SOURCE: Wellgistics Health Secures $50M ELOC Facility for XRP Treasury Reserve and Real-Time Payments Infrastructure and Other General Ops
Via ACCESS Newswire
Wellgistics Health Secures $50M Credit Facility and Launches XRP-Powered Payment Initiative
Via ACCESS Newswire
Wellgistics Health Reports Strong Q1 Operational Growth Across Manufacturer, Product, and Pharmacy Expansion with Over 350 New Pharmacies Added to Its Nationwide Network
Via ACCESS Newswire
Wellgistics Names Mark DiSiena as New CFO
Via ACCESS Newswire
CEO of Wellgistics Health Converts $1.5 Million of Debt to Equity at IPO Price
Via ACCESS Newswire
Wellgistics Health, Inc. Announces Agreement to Acquire Peek Healthcare Technologies, Inc., to Support Over 2,500 Patients and $1.5MM Annual Revenue
Via ACCESS Newswire
D. Boral Capital Served as Joint Bookrunner to Wellgistics Health, Inc. (Nasdaq: WGRX) in connection with its $4.0 Million Initial Public Offering
Via ACCESS Newswire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.